Parsagen Diagnostics

Curated by Signal

POC device for diagnosis of high-risk pregnancy

Overview

Parsagen is an early stage diagnostic company engaged in the development of point-of-care diagnostics in the field of high-risk pregnancy and prematurity. The company's first product is a rapid, non-invasive test that will help clinicians in predicting preterm birth within 7 and 14 days of presentation. The company received 1 Million USD through the prestigious Massachusetts Life Sciences Center accelerator program in 2015.

Key facts

Founded: 2014
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Genesist
Developer of CRISPR-based therapies to stop cancer metastasis and recurrence
Life Sciences TechnologyFarmington, United States
Brazen
Developer of herbal supplement for PMS relief
Life Sciences TechnologyAustin, United States
ICBiome
Provider of software solutions for pathogen detection
Life Sciences TechnologySterling, United States

About Parsagen Diagnostics

What does Parsagen Diagnostics do?

Parsagen is an early stage diagnostic company engaged in the development of point-of-care diagnostics in the field of high-risk pregnancy and prematurity.

Where is Parsagen Diagnostics headquartered?

Parsagen Diagnostics is headquartered in Boston, United States.

When was Parsagen Diagnostics founded?

Parsagen Diagnostics was founded in 2014.

Which sector is Parsagen Diagnostics in?

Parsagen Diagnostics operates in Life Sciences Technology.

Who are Parsagen Diagnostics's competitors?

Companies similar to Parsagen Diagnostics include Genesist, Brazen, and ICBiome.